Finance

Lists
IKT:NASDAQ
Inhibikase Therapeutics Inc
၁.၈၆ US$
+၀.၅၄%
(+၀.၀၁၀၀) 1D
အောက် ၁၃, GMT-၄ ၁၀:၀၇:၁၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IKT...
Open
၁.၈၅ US$
High
၁.၈၈ US$
Low
၁.၈၁ US$
Mkt. cap
၂၅.၈၈ ကုဋေ
Avg. vol.
၅.၄၀ သိန်း
Volume
၄.၉၃ သောင်း
52-wk high
၂.၆၁ US$
52-wk low
၁.၃၃ US$
EPS
-၀.၄၄ US$
Beta
၀.၈၉
Shares outstanding
၁၃.၉၅ ကုဋေ
No. of employees
၃၅
Open
၁.၈၅ US$
High
၁.၈၈ US$
Low
၁.၈၁ US$
Mkt. cap
၂၅.၈၈ ကုဋေ
Avg. vol.
၅.၄၀ သိန်း
Volume
၄.၉၃ သောင်း
52-wk high
၂.၆၁ US$
52-wk low
၁.၃၃ US$
EPS
-၀.၄၄ US$
Beta
၀.၈၉
Shares outstanding
၁၃.၉၅ ကုဋေ
No. of employees
၃၅
News stories
From web sources and news partners
Investing.com
Investing.com
·
ပြီးခဲ့သည့် ၅ နာရီ
Chardan initiates Inhibikase Therapeutics stock with neutral rating
About Inhibikase Therapeutics Inc
CEO-
Employees၃၅
Founded၂၀၀၈
HeadquartersWilmington, ဒယ်လာဝဲပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 6 analysts giving stock ratings to IKT in the past 3 months
Strong buy
Buy
5
Hold
1
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for IKT in the last 3 months.
Highest
Current ၁.၈၆ US$
၈.၀၀ US$ (+၃၃၁.၂၇%)
Average
၅.၅၈ US$ (+၂၀၀.၈၁%)
Lowest
၁.၅၀ US$ (-၁၉.၁၄%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andreas Argyrides
Chardan Capital
Hold
Initiated
၁.၅၀ US$
-၁၉.၁%
10/13/2026
Gaurav Maini
LifeSci Capital
Buy
Maintained
၅.၀၀ US$
+၁၆၉.၅%
09/15/2026
Jason McCarthy
Maxim Group
Buy
Maintained
၈.၀၀ US$
+၃၃၁.၃%
08/13/2026
Mazahir Alimohamed
Oppenheimer
Buy
Maintained
၅.၀၀ US$
+၁၆၉.၅%
08/12/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
၈.၀၀ US$
+၃၃၁.၃%
07/31/2026
Jason Zemansky
Bank of America Securities
Buy
Maintained
၆.၀၀ US$
+၂၂၃.၅%
07/27/2026
Olivia Brayer
Cantor Fitzgerald
Buy
Maintained
၄.၀၀ US$
+၁၁၅.၆%
05/18/2026
Aydin Huseynov
Ladenburg Thalmann & Co.
Buy
Initiated
၄.၀၀ US$
+၁၁၅.၆%
03/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
၇.၆၅ သန်း
-၂.၃၄ ကုဋေ
-
-
Cost of revenue
၇.၆၅ သန်း
-၂.၃၄ ကုဋေ
-
-
Research and development expenses
-
၂.၂၄ ကုဋေ
၁.၀၈ ကုဋေ
၁.၃၄ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၅.၆၁ သန်း
၆.၇၇ သန်း
၇.၃၈ သန်း
၇.၆၆ သန်း
Operating expense
၅.၆၁ သန်း
၂.၉၂ ကုဋေ
၁.၈၂ ကုဋေ
၂.၁၁ ကုဋေ
Total operating expenses
၁.၃၃ ကုဋေ
၅.၇၃ သန်း
၁.၈၂ ကုဋေ
၂.၁၁ ကုဋေ
Operating income
-၁.၃၃ ကုဋေ
-၅.၇၃ သန်း
-၁.၈၂ ကုဋေ
-၂.၁၁ ကုဋေ
Other non operating income
-
-
၁.၄၆ သန်း
၁.၄၆ သန်း
EBT including unusual items
-၁.၁၉ ကုဋေ
-၁.၂၇ ကုဋေ
-၁.၆၄ ကုဋေ
-၁.၉၆ ကုဋေ
EBT excluding unusual items
-၁.၂၄ ကုဋေ
-၄.၆၉ သန်း
-၁.၆၈ ကုဋေ
-၁.၉၆ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၁.၁၉ ကုဋေ
-၁.၂၇ ကုဋေ
-၁.၆၄ ကုဋေ
-၁.၉၆ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-
-
-၀.၁၀
-၀.၁၁
Interest and investment income
၈.၃၈ သိန်း
၁.၀၄ သန်း
-
-
Interest expense
-
-
-
-
Net interest expenses
၈.၃၈ သိန်း
၁.၀၄ သန်း
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၃၂ ကုဋေ
-၅.၇၃ သန်း
-၁.၈၂ ကုဋေ
-၂.၁၀ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ